10.14.25 -- Advancing Biotherapeutics With Integrated Bioanalytic Solutions

Join 1,000+ pharma, biotech, and drug delivery professionals at the PODD: Partnership Opportunities in Drug Delivery Conference conference, October 27–28 in Boston. Featuring 10 technology tracks, pharma company spotlights, 1:1 partnering, and more. Attendees will also hear from leaders at companies including AbbVie, Amgen, AstraZeneca, Biogen, Eli Lilly, GSK, Moderna, Novartis, Pfizer, Regeneron, Roche, Sanofi, Takeda, and others. Register at PODDConference.com with code LSL20 for 20% off.

Understand why continued research and collaboration between industry and regulatory bodies are essential to define guidelines that ensure safety and efficacy in this rapidly advancing field.

Our expertise and integrated service offering enable us to rapidly execute multiple projects from our state-of-the-art cGMP facilities while ensuring full process and product compliance.

Employ expert teams to deliver statistical and risk analysis support encompassing viral, microbiological, molecular biological, biological, and physicochemical testing.

Learn how a bioanalytical testing partner with comprehensive solutions and unwavering commitment to quality can help you bring safe and effective drugs to market with confidence.

Our integrated approach brings together drug substance, drug product and clinical activities, supporting the expediting of lead molecules from FIH into POC trials.

Overcome ADC development challenges with testing services that ensure molecular stability, regulatory compliance, and optimized formulations to accelerate market readiness and reduce risks.

Characterizing a molecule's identity enables efficient process development and regulatory compliance. To achieve this, sponsors must leverage advanced analytical techniques.

With extensive clinical and commercial expertise, we offer the experience and capacity to be your trusted partner in recombinant protein and monoclonal antibody manufacturing.

See how leveraging the expertise and flexibility of a partner empowers teams to ensure regulatory compliance from the outset, with thorough characterization starting at the earliest stages.

Develop a robust analytical strategy to ensure the quality and consistency of your antibody-drug conjugate by evaluating each component and navigating multi-site manufacturing complexities.